advertisement
advertisement
advertisement

Is it truly over for Theranos?

Theranos, the fallen unicorn, this week voided two years of test results according to a report in the Wall Street Journal. The company must still have some money in the bank—it raised more than $680 million in cash—but the Internet is damn near convinced that there’s no future for the blood-testing startup. 

CF